|
Evaluation of serum levels and significance of soluble CD40 ligand in screening
patients with hepatitis C virus-related hepatocellular carcinoma
Eltaher SM, El-Gil R, Fouad N, Mitwali R, El-Kholy H.
East Mediterr Health J. 2016 Nov
2;22(8):603-610
.Abstract
Detection of Hepatitis C core antibody by dual-affinity yeast chimera and
smartphone-based electrochemical sensing.
Aronoff-Spencer E,
Venkatesh AG, Sun A,
et al
Biosens Bioelectron.
2016 Dec 15;86:690-6.
Abstract
FULL-TEXT ARTICLE
Gold aggregating gold: A novel nanoparticle biosensor approach for the direct
quantification of hepatitis C virus RNA in clinical samples.
Shawky SM, Awad AM, Allam W,
et al
Biosens Bioelectron. 2016
Nov 4.
Paper
Evaluation of serum levels and significance of soluble CD40 ligand in screening
patients with hepatitis C virus-related hepatocellular carcinoma.
Eltaher SM, El-Gil R,
Fouad N,
et al
East Mediterr Health
J.
2016 Nov 2;22(8):603-610.
Abstract
Advances in the Diagnosis and Monitoring of Hepatitis C Virus
Infection.
Ciotti M, D'Agostini C,
Marrone A.
Gastroenterology Res.
2013 Oct;6(5):161-170..
Abstract
Ultrastructural organisation of HCV from the bloodstream of
infected patients revealed by electron microscopy after specific
immunocapture.
Piver E, Boyer A, Gaillard J,
et al
Gut.
2016 Oct 11
Abstract
Detection of Hepatitis C core antibody by dual-affinity yeast chimera and
smartphone-based electrochemical sensing.
Aronoff-Spencer E, Venkatesh AG, Sun A,
Biosens Bioelectron.
2016 Dec 15;86:690-6.
Abstract
Simple Predictive Model for Identifying Patients with Chronic
Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High
Probability of Sustained Virologic Response with Peginterferon
Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International
Cohort Studies.
Asselah T, Esmat G, Sanai FM,
et al
Adv Ther.
2016 Aug 12
Abstract
Analytical performance of the VERIS MDx system HCV assay for detecting and
quantifying HCV RNA.
Sauné K, Abravanel F, Haslé
C, et al
J Clin Virol. 2016 Sep
13;84:7-11
Abstract
Evaluation of LIAISON® XL system for HBsAg, and anti-HCV and
anti-HIV/Ag p24.
De Paschale M, Manco MT, Belvisi L,
et al
J Med Virol.
2016 Jul 28.
Abstract
FULL-TEXT ARTICLE
Visualizing
the hepatic vascular architecture using superb microvascular imaging in
patients with hepatitis C virus: A novel technique.
Kuroda H, Abe T, Kakisaka K,
et al
World J Gastroenterol.
2016 Jul 14;22(26):6057-
Paper
Development and Validation of a Template-Independent
Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated
Variants of Hepatitis C Virus.
Wei B, Kang J, Kibukawa M, Chen L
J Mol Diagn.
2016 Jul 6.
Abstract
Nomogram for individualized prediction of hepatocellular
carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
Ganne-Carrié N, Layese R, Bourcier V, et al
Hepatology. 2016 Jun 27.
Abstract
Structural Changes In Cells Imaged by Soft X-Ray Cryo-Tomography During
Hepatitis C Virus Infection.
Pérez-Berná
AJ, Rodríguez MJ, et al
ACS Nano. 2016
Jun 21
Abstract
Clinical efficacy of the highly sensitive hepatitis C virus RNA quantitative
assay in patients with relapse following interferon-based therapy with
second-generation direct-acting antivirals.
Ishikawa T, Abe S, Watanabe T, et
al
Biomed Rep.
2016 Jun;4(6):664-666.
Abstract
An Accurate Assay for HCV Based on Real-Time Fluorescence Detection of
Isothermal RNA Amplification.
Wu X, Wang J, Song J, et al
J Virol Methods.
2016 Jun 6.
Abstract
Deep sequencing increases hepatitis C virus phylogenetic cluster detection
compared to Sanger sequencing.
Montoya V, Olmstead A, Tang P,
et
al
Infect
Genet Evol. 2016 Jun 6.
Abstract
Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in
Hepatitis C-Monoinfected and Human Immunodeficiency Virus/ Hepatitis
C-Coinfected Patients.
Verlinden W, Bourgeois S, Gigase P,
et al
J Ultrasound Med. 2016
May 5.
Abstract
Multiple approaches to assess fourteen non-invasive serum indexes for the
diagnosis of liver fibrosis in chronic hepatitis C patients.
Andrés-Otero
MJ, De-Blas-Giral I, et al
Clin
Biochem. 2016 Mar 9.
Abstract
Multicenter clinical evaluation of the new 3rd generation assay for
detection of antibodies against hepatitis C virus on the VIDAS®
system
Seignčres B, Descamps F, Croise R, et al
J
Clin Virol. 2016 Mar
4;78:20-2
Abstract
HCV false positive immunoassays in patients with LVAD: A potential trap!
Heinrichs A, Antoine M, Steensels D,
et al
Clin Virol.
2016 Mar 10;78:44-46.
Abstract
Amplification and pyrosequencing of near-full-length hepatitis C virus for
typing and Monitoring antiviral Resistant Strains.
Trémeaux P, Caporossi A, Ramičre C, et al
Clin Microbiol Infect. 2016 Jan 28
Abstract
Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus
genotyping in drug users in Senegal.
Ndiaye O, Gozlan J, Diop-Ndiaye H,
et al
J Med Virol. 2015 Dec
24.
Abstract
Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis
C patients.
Verlinden W, Bourgeois S, De Maeyer M,
et al
Acta Gastroenterol Belg.
2015 Oct-Dec;78(4):373-80
Abstract
Analysis of Hepatitis C NS5A resistance associated
polymorphisms using ultra deep single molecule real time (SMRT) sequencing.
Bergfors A, Leenheer D, Bergqvist A,
et al
Antiviral Res.
2015 Dec 18.
Abstract
Comparison of Elecsys Anti-HCV II Assay With Other HCV Screening Assays.
Li D, Zhu S, Wang T, et al
J Clin Lab Anal. 2015
Dec 14
Abstract
Impact of HCV kinetics on treatment outcome differs by the type of
real-time HCV assay in NS3/4A protease inhibitor-based triple therapy.
Ogawa E, Furusyo N, Murata M, et al
Antiviral Res. 2015 Dec
12.
Abstract
The Diagnostic Impact of C4d, CD68, and NF-κB Expression in
the Differentiation Between Recurrent Hepatitis C and Acute Cellular
Rejection After Liver Transplantation.
Abdou AG, Asaad NY, Ehsan N,
Appl Immunohistochem Mol Morphol. 2015 Oct
13.
Abstract
Ultra-deep sequencing provides insights into the virology of
hepatitis C super-infections in a case of three sequential infections with
different genotypes.
Chung E, Ferns RB, He M,
et
al
J Clin Virol. 2015 Sep;70:63-6.
Abstract
FULL-TEXT ARTICLE
The Usefulness of Defining Rapid Virological Response by a Very Sensitive
Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.
Dalgard O, Martinot-Peignoux M, Verbaan H, et al
PLoS One. 2015 Aug
28;10(8):e0120866.
Paper
Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in
hepatitis C virus (HCV) genotype 1a strains in the United Kingdom.
Beloukas A, King S,
Childs K, Papadimitropoulos A, et al
Clin Microbiol Infect.
2015 Jul 29.
Abstract
FULL-TEXT ARTICLE
Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with
Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
Tachi Y, Hirai T, Toyoda H, et al
PLoS One. 2015 Jul
27;10(7):e0133515.
Paper
Simplified diagnostic monitoring for hepatitis C, in the new
era of direct-acting antiviral treatment.
Cohn J, Roberts T,
Amorosa V, et al
Curr Opin HIV AIDS. 2015 Jul 17
Abstract
Development and validation of two screening assays for the HCV NS3 Q80K
polymorphism associated with reduced response to combination treatment
regimens containing simeprevir.
Chui CK, Dong WW, Joy JB, et al
J Clin Microbiol.
2015 Jul 1.
Abstract
Diagnostic accuracy of algorithms to identify hepatitis C status, AIDS
status, alcohol consumption and illicit drug use among patients living with
HIV in an administrative healthcare database.
Durand M, Wang Y, Venne F, Lelorier J,
et al
Pharmacoepidemiol Drug Saf.
2015 Jun
24
Abstract
FULL-TEXT ARTICLE
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant
(NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay.
Yoshimi S, Ochi H, Murakami E, et al
PLoS One. 2015 Jun
17;10(6):e0130022.
Paper
FULL-TEXT ARTICLE
Rapid detection of HCV genotyping 1a, 1b, 2a, 3a, 3b and 6a in a single
reaction using two-melting temperature codes by a real-time PCR-based assay
Athar MA, Xu Y, Xie X, et al
J Virol Methods.
2015 Jun 9
Paper
Utility of Hepatitis C Viral Load Monitoring On Directly
Acting Antiviral Therapy.
Sidharthan S, Kohli
A, Sims Z, et al
Clin Infect Dis.
2015 Mar 2.
Abstract
High Resolution Melting Curve Assay for Detecting rs12979860
IL28B Polymorphisms Involved in Response of Iranian Patients to Chronic
Hepatitis C Treatment.
Fateh A, Aghasadeghi MR, Keyvani
H, et al
Asian Pac J Cancer Prev.
2015;16(5):1873-80.
Abstract
Differentiation of acute from chronic hepatitis C virus
infection by NS5B deep sequencing: A population-level tool for incidence
estimation.
Montoya V, Olmstead A, Janjua NZ, et al
Hepatology. 2015 Feb
2.
Abstract
Determination of the HCV protease inhibitor telaprevir in
plasma and dried blood spot by liquid chromatography tandem mass
spectrometry.
Verweij-van Wissen
CP, de Graaff-Teulen MJ, et al
Ther Drug Monit. 2015 Jan 26.
Abstract
Magnetic resonance sialography of the parotid glands in chronic hepatitis C
virus patients with and without vasculitis.
Shahin AA, Hussein H, Gaber W, et
al
Int J Rheum Dis. 2014 Dec 23
Abstract
Importance of very early HCV RNA kinetics for prediction of
treatment outcome of highly effective all oral direct acting antiviral
combination therapy.
Sarrazin C,
Wedemeyer H, Cloherty G,
et al
J Virol Methods. 2014 Dec 18. pii:
S0166-0934(14)00474-1
Abstract
FULL=TEXT
ARTICLE
MicroRNA
Expression Profiling in PBMCs: A Potential Diagnostic Biomarker of Chronic
Hepatitis C.
Chang CC, Lin CC, Hsieh WL, et
al
Dis Markers.
2014;2014:367157
Paper
Ultrasound Elastography Correlates Treatment Response by Antiviral Therapy
in Patients with Chronic Hepatitis C.
Yada N, Sakurai T, Minami T, et al
Oncology. 2014;87 Suppl 1:118-
Abstract
Noninvasive Diagnosis of Liver Fibrosis: Utility of Data
Mining of Both Ultrasound Elastography and Serological Findings to Construct
a Decision Tree.
Yada N, Kudo
M, Kawada N, et al
Oncology.
2014;87 Suppl 1:63-72.
Abstract
Variation analysis of six HCV viral load assays using low viremic HCV
samples in the range of the clinical decision points for HCV protease
inhibitors.
Wiesmann F, Naeth G, Sarrazin C, et al.
Med Microbiol Immunol.
2014 Nov 15
Abstract
High-resolution Hepatitis C virus (HCV) subtyping, using NS5B
deep sequencing and phylogeny, an alternative to current methods.
Quer J, Gregori J, Rodríguez-Frias F, et
al
J Clin Microbiol.
2014 Nov 5.
Abstract
Dried blood spot in the genotyping, quantification and
storage of HCV RNA: a systematic literature review.
Greenman J, Roberts T, Cohn J, Messac L.
J Viral Hepat. 2014 Nov 4
Abstract
FULL-TEXT ARTICLE
Molecular diagnostics in the management of chronic hepatitis C: key
considerations in the era of new antiviral therapies.
Cobb B, Heilek G, Vilchez RA.
BMC Infect Dis. 2014 Sep 5;14 Suppl 5:S8.
doi: 10.1186/1471-2334-14-S5-S8
Paper
FULL-TEXT ARTICLE
Similar Prevalence of Low-Abundance Drug-Resistant Variants in
Treatment-Naive Patients with Genotype 1a and 1b Hepatitis C Virus
Infections as Determined by Ultradeep Pyrosequencing.
Margeridon-Thermet S, Le Pogam S, et
al
PLoS One. 2014 Aug 20;9(8):e105569.
Paper
Development of a high-throughput pyrosequencing assay for monitoring
temporal evolution and resistance associated variant emergence in the
Hepatitis C virus protease coding-region.
Irving WL, Rupp D, McClure CP,
Antiviral Res. 2014
Jul 21
Abstract
High-throughput and sensitive next-generation droplet digital
PCR assay for the quantitation of the hepatitis C virus mutation at core
amino acid 70.
Mukaide M, Sugiyama M, Korenaga M,
et al
J Virol Methods. 2014 Jul 11
Abstract
A reliable multiplex genotyping assay for HCV using a
suspension bead array.
Yang YC, Wang DY,
Cheng HF, et al
Microb Biotechnol. 2014 Jul 10
Abstract
Clinical utility of hepatitis C virus core antigen quantification in
patients with chronic hepatitis C.
Chevaliez S, Soulier A, Poiteau L, et al
J Clin Virol. 2014 Jun
2
Abstract
HCV treatment revolution: needs for close monitoring.
Ippolito G, Antonelli G,
Capobianchi MR, Lanini S.
Clin Microbiol Infect. 2014 May 28.
Abstract
Diagnostic accuracy evaluation of the ImmunoFlow HCV rapid
immunochromatographic test for the detection of hepatitis C antibodies.
Kosack CS, Nick S, Shanks L.
J
Virol Methods. 2014 Apr 12.
Abstract
FULL-TEXT ARTICLE
Useful
biomarkers for assessment of hepatitis C virus infection-associated
autoimmune disorders.
Yang DH, Ho LJ, Lai JH.
World J Gastroenterol.
2014 Mar 21;20(11):2962-2970
Paper
FULL-TEXT
ARTICLE
A
Screen for Genetic Suppressor Elements of Hepatitis C Virus Identifies a
Supercharged Protein Inhibitor of Viral Replication.
Simeon RL, Chen Z.
PLoS One. 2013
Dec 31;8(12):e84022
Paper
Diagnostic accuracy of serum glypican-3 for hepatocellular
carcinoma: A systematic review and meta-analysis.
Liu XF, Hu ZD, Liu XC, et
al
Clin Biochem.
2013 Dec 18
Abstract
Fast, reliable and low cost user-developed protocol for
detection, quantification and genotyping of hepatitis C virus.
Davalieva K, Kiprijanovska S,
Plaseska-Karanfilska D.
J Virol
Methods. 2013 Nov 21
Abstract
Direct visualization of HCV-infected Huh7.5 cells with a high-titer infectious
chimeric JFH1-EGFP reporter virus in 3D matrigel cell cultures.
Liu S, Chen R, Hagedorn C.
J Gen Virol. 2013 Nov 16.
Abstract
Hepatitis C virus core antigen testing in liver and kidney transplant
recipients.
Heidrich B, Pischke S, Helfritz FA, et al
J Viral Hepat. 2013 Nov 19.
Abstract
Development and Characterization of a Replicon-based Phenotypic Assay for
Assessing HCV NS4B from Clinical Isolates.
Rajyaguru S, Yang H, Martin R,
et al
Antiviral Res. 2013 Sep 4.
Abstract
Liver stiffness measurement by acoustic radiation force impulse
is useful in predicting the presence of esophageal varices or high-risk
esophageal varices among patients with HCV-related cirrhosis.
Morishita N, Hiramatsu N, Oze T,
et al
J
Gastroenterol. 2013 Sep 5.
Abstract
Rapid detection and identification of hepatitis C virus (HCV)
sequences using mismatch-tolerant hybridization probes: A general method for
analysis of sequence variation.
Pierce KE, Wangh LJ.
Biotechniques. 2013 Sep;55(3):125-32
Abstract
The End-of-Treatment Ribavirin Concentration Predicts Hepatitis C Virus Relapse.
Bodeau S,
Durand-Maugard C, Lemaire-Hurtel AS, et al
Ther Drug
Monit. 2013 Aug 12.
Abstract
FULL-TEXT PDF ARTICLE
A new type
of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies
in the sera of hepatitis C virus-positive patients.
Akada J, Kamei S, Ito A, et al
Proteome Sci. 2013 Jul 19;11(1):33
Abstract
A Diagnostic Score for the Prediction of Spontaneous Resolution
of Acute Hepatitis C Virus Infection.
Beinhardt S, Anna Payer B, Datz C, et al
J Hepatol.
2013 Jul 10
Abstract
Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pyne MT, Hillyard DR.
Diagn Microbiol Infect Dis.
2013 Jun 24.
Abstract
A Novel Single Step Multiplex Real Time Pcr Assay for Simultaneous
Quantification of Hepatitis Virus A, B, C & E in Serum.
Irshad M, Ansari MA, I K, L R.J
Gastroenterol Hepatol.
2013 Jun 25
Abstract
Nucleotide polymorphisms in the 5'-UTR region of HCV can affect
the ability of two widely used assays to assign an HCV genotype.
Pollicita M, Cento V, Paba P, et al
J Virol Methods. 2013 Jun 19.
Abstract
Development of diagnostic methods and study of the immunoreactivity of a
mixture of recombinant core and E2 proteins fused to GST with control serum
positive for hepatitis C.
Kenfe FR, Urbaczek AC, Silva JC, et al
Talanta. 2013 Jun 15;110:32-8
Abstract
Hepatitis C virus subtyping based on sequencing of the C/E1 and
NS5B genomic regions in comparison to a commercially available line probe
assay
Avó AP, Agua-Doce I, Andrade A, Pádua
E.
J Med Virol.
2013 May;85(5):815-22.
Abstract
Detection of infections with hepatitis B virus, hepatitis C
virus, and human immunodeficiency virus by analyses of dried blood spots -
performance characteristics of the ARCHITECT system and two commercial
assays for nucleic acid amplification.
Ross RS, Stambouli O, Grüner N,
et al
Virol J. 2013 Mar 5;10:72
Abstract
Development of a nucleic Acid lateral flow strip for detection of hepatitis C
virus (HCV) core antigen.
Wang C, Zhang L, Shen X.
Nucleosides Nucleotides Nucleic Acids.
2013;32(2):59-68
Abstract
n situ hybridization for the detection of hepatitis C virus RNA
in human liver tissue.
Li G, Li K, Lea AS, et al
J Viral Hepat.
2013 Mar;20(3):183-92.
Abstract
A hepatitis C avidity test for determining recent and past
infections in both plasma and dried blood spots.
Shepherd SJ, Kean J, Hutchinson SJ,
et al
J Clin Virol. 2013 Jan 28..
Abstract |
General/Misc. Reports
Diagnostic
Challenges